Laval co-leads international lab using AI and multi-omics to study emerging infectious diseases
Université Laval is part of a new International Associated Laboratory (LIA) combining artificial intelligence and multi-omics to study emerging infectious diseases. Two Laval medicine professors will lead the initiative. The partnership with Université Paris Cité and Inserm targets research, graduate training and shared access to advanced expertise and infrastructures.
Announced 19 November 2026, the LIA brings together teams from Université Laval, Université Paris Cité and Inserm to develop AI-enabled, multi-omics approaches for understanding and combating emerging pathogens. Professor Arnaud Droit will co-direct the lab and Professor Jérôme Estaquier serves as scientific director. The initiative emphasizes trainee formation, pooling of high-end infrastructures and cross‑institutional expertise to better anticipate and respond to future infectious threats.
Read the original story · Université Laval — médecine — https://www.fmed.ulaval.ca/nouvelles/detail-dune-nouvelle/la-faculte-de-medecine-au-coeur-dun-nouveau-laboratoire-international-sur-les-maladies-infectieuses